- Home
- SNN
as 11-20-2024 4:00pm EST
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
| Founded: | 1856 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 10.8B | IPO Year: | 1999 |
| Target Price: | N/A | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.35 | EPS Growth: | 39.77 |
| 52 Week Low/High: | $23.65 - $31.72 | Next Earning Date: | 08-01-2024 |
| Revenue: | $5,642,000,000 | Revenue Growth: | 5.48% |
| Revenue Growth (this year): | 6.97% | Revenue Growth (next year): | 5.46% |
Latest Smith & Nephew SNATS Inc. News
SNN Breaking Stock News: Dive into SNN Ticker-Specific Updates for Smart Investing
Simply Wall St.
7 days ago
ConvaTec Group And 2 Other UK Stocks That May Be Priced Below Their Estimated Value
Simply Wall St.
20 days ago
Smith & Nephew (LON:SN.) investors are sitting on a loss of 25% if they invested five years ago
Morningstar Research
21 days ago
Analyst Report: Smith & Nephew plc
Morningstar Research
21 days ago
Analyst Report: Smith & Nephew plc
The Wall Street Journal
21 days ago
Health Care Roundup: Market Talk
GlobeNewswire
a month ago
RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
Simply Wall St.
a month ago
UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024
Zacks
a month ago
SNN Stock May Gain Following the Co-Marketing Deal With JointVue
Compare SNN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNN Smith & Nephew SNATS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.